NASDAQ:EOLS

Evolus Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy EOLS

*Your capital is at risk

$6.03

-0.140 (-2.27%)

At Close: Jun 03, 2026

Evolus Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -25.96. In total, the insiders bought 4.65M and sold 822.79K EOLS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-25.96
● Buy	4.65M shares
● Sell	822.79K shares
70% Buy Activity Strong Negative Correlation
Sell Signal Medium Confidence Mar 17, 2026 Analysis Breakdown: Supported by a negative Insider Power Score of -25.96. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Sep 08, 2025 Buy	Common Stock A-Award	Mitchell Tatjana Chief Financial Officer	C-Suite Officer	104 603 Value: $796.0K
Sep 08, 2025 Buy	Common Stock J-Other	Mitchell Tatjana Officer	Officer	0 Value: $0
Sep 08, 2025 Buy	Common Stock J-Other	Mitchell Tatjana Officer	Officer	0 Value: $0
Sep 08, 2025 Buy	Common Stock A-Award	Mitchell Tatjana Chief Financial Officer	C-Suite Officer	104 603 Value: $796.0K
Sep 08, 2025 Buy	Stock Option (Right to Buy) A-Award	Mitchell Tatjana Chief Financial Officer	C-Suite Officer	143 403 Value: $1.09M
Aug 22, 2025 Sell	Common Stock S-Sale	Yamagishi-dressler Tomoko Chief Marketing Officer	Officer	5 722 Value: $43.0K
Aug 22, 2025 Sell	Common Stock S-Sale	Yamagishi-dressler Tomoko Chief Marketing Officer	Officer	5 722 Value: $43.0K
Aug 15, 2025 Buy	Common Stock P-Purchase	Stewart Brady Director	Director	30 000 Value: $204.5K
Aug 15, 2025 Buy	Common Stock P-Purchase	Stewart Brady Director	Director	30 000 Value: $204.5K
Jun 16, 2025 Sell	Common Stock S-Sale	Moatazedi David See Remarks	Officer	16 582 Value: $164.1K
Jun 16, 2025 Sell	Common Stock S-Sale	Moatazedi David See Remarks	Officer	16 582 Value: $164.1K
Jun 13, 2025 Sell	Common Stock S-Sale	Moatazedi David See Remarks	Officer	111 323 Value: $1.12M
Jun 13, 2025 Sell	Common Stock S-Sale	Moatazedi David See Remarks	Officer	111 323 Value: $1.12M
Jun 09, 2025 Buy	Common Stock P-Purchase	White Albert G Iii Director	Director	20 000 Value: $189.0K
Jun 09, 2025 Buy	Common Stock P-Purchase	White Albert G Iii Director	Director	20 000 Value: $189.0K
May 13, 2025 Sell	Common Stock S-Sale	Beaver Sandra Chief Financial Officer	C-Suite Officer	6 494 Value: $65.1K
May 13, 2025 Sell	Common Stock S-Sale	Beaver Sandra Chief Financial Officer	C-Suite Officer	6 494 Value: $65.1K
May 12, 2025 Sell	Common Stock S-Sale	Avelar Rui See Remarks	Officer	3 385 Value: $33.4K
May 12, 2025 Sell	Common Stock S-Sale	Moatazedi David See Remarks	Officer	15 787 Value: $155.8K
May 12, 2025 Sell	Common Stock S-Sale	Moatazedi David See Remarks	Officer	15 787 Value: $155.8K
May 12, 2025 Sell	Common Stock S-Sale	Avelar Rui See Remarks	Officer	3 385 Value: $33.4K
Mar 27, 2025 Sell	Common Stock S-Sale	Moatazedi David See Remarks	Officer	6 251 Value: $77.5K
Mar 27, 2025 Sell	Common Stock S-Sale	Moatazedi David See Remarks	Officer	6 251 Value: $77.5K
Mar 18, 2025 Sell	Common Stock S-Sale	Avelar Rui See Remarks	Officer	27 904 Value: $369.9K
Mar 18, 2025 Sell	Common Stock S-Sale	Beaver Sandra Chief Financial Officer	C-Suite Officer	8 996 Value: $119.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT EVOLUS INC.

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California....

Read Full Profile Here